Pharmaceuticals - Community Register


Community register of medicinal products for human use


Product information

Invented name: Tresiba   
Auth. number : EU/1/12/807
INN : Insulin degludec
ATC: Pending
Indication: Treatment of diabetes mellitus in adults
Marketing Authorisation Holder: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/01/2013 Centralised - Authorisation EMEA/H/C/2498 (2013)637 of 21/01/2013
13/03/2013 Corrigendum (2013)1533 of 12/03/2013
06/05/2013 Centralised - Variation EMEA/H/C/2498/IAin/3
06/05/2013 Centralised - Variation EMEA/H/C/2498/IAin/4/G